Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 17;10:15295. doi: 10.1038/s41598-020-72247-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

sCD14 levels accurately predict disease progression rates and survival times. (A) Serum sCD14 levels were an indicator of disease progression rates. (B) In a larger cohort of patients, serum sCD14 levels were an indicator of disease progression rates. (C) Seventy-two percent of patients who had sCD14 values above the cutoff were deceased while 28% of patients with sCD14 values below the cutoff were deceased. (D) Patients with a ROC score above the cutoff reached 100 AALS points faster than those patients with a score below the cutoff. (E) Patients with ROC scores above the cutoff lived a shorter period of time from diagnosis than those patients with scores below the cutoff. (G) The greater the amounts of serum sCD14, the faster the patients reached 100 AALS points. (J) The greater the amounts of serum sCD14 the faster the patients’ time from diagnosis to death.